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Background: Adherence to guideline directed medical therapy
(GDMT) althoughmandatory after CABG& percutaneous coronary
intervention (PCI), is often sub-optimal at hospital discharge.
Since relevant data are lacking from our country, we performed a
retrospective analysis of medication advice following CABG and
PCI from 2010-2013.
Methods: A total of 5258 records (PCI/CABG:86.2vs13.8%) were
studied.
Results: Presentation with stable angina was commoner in CABG
group (61.4 vs 39.4%, p<0.001) while ACS was more in PCI group
(61.6 vs 38.9% p<0.001). Prescription rates for dual anti-platelets
(aspirin 100% vs 99%, clopidogrel 100% vs 96.9%), beta blockers
(98.4% vs 93.7%) and statins (99.1% vs 90.9%) were similar in PCI &
CABG groups. ACE inhibitors (94.2% vs 47.2%) & nitrates (58.2% vs
0.8%, both p < 0.001) were prescribed more often post-PCI. Despite
similar LVEF (46.8% vs 48.2%), diuretics were prescribed univer-
sally post- CABG (99.1% vs 14.8%, p<0.001). Calcium channel
blockers were prescribed in < 5% & more often post PCI (4.9 vs
2.2%, p<0.001).
Drug doses: For Aspirin, 150 mg OD was the commonest dose
used (94.6% vs 88.2%; PCI/CABG). Clopidogrel 75 mg BD was used
more often post PCI (82.5% vs 1.7%) while 75 mg od more post
CABG (6.4% vs 95.2%). Statin 40-80 mg was prescribed more often
post PCI (68.2% vs 0.3% and 9.8% vs 0% respectively, p0.001). Statin
10 mg was used in 82.5% post CABG vs 5.4% post PCI (p 0.001). A 50
mg dose of betablocker was used in 74.2% post PCI vs 42.1% post
CABG; 25 mg betablokcer was prescribed in 47% and 21.1% of post
CABG & post PCI patients (all p< 0.01).
Conclusions: Significant differences in prescription of GDMT exist
at hospital discharge even in a tertiary centre. Post CABG, 7% and
53% patients were not prescribed a betablokcer & ACEI respec-
tively. Post CABG, patients were less likely to receive high dose
statinor optimal betablokcer dose&more likely to receivediuretics
(irrespective of EF). Post-PCI, 80 mg statin was used in < 10%. Such
evidence practice gaps need to be rectified to improve cardiac care.
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Background: Erectile Dysfunction (ED) is an important and
growing health problem. It is estimated that more than 200
millionmen (between the age of 40e 70 years) suffer from ED. The
real prevalence could be much higher as it is underreported and
undertreated. Out of the many etiologies, 80% of cases are of
vasculogenic origin. Venous leak and arterial inflow problems
(usually pudendal artery stenosis) are the most common
etiologies. In patients who fail PDEe5 inhibitors therapy (Complex
ED), vasculogenic causes should be strongly suspected.
Methods: The workup is done by excluding the endocrinal, uro-
logical and psychological causes and then subjecting these pa-
tients to a penile Doppler study (after intra cavernosal injection of
papaverine). In patients where the peak systolic penile velocity is
less than 25cm/sec, pudendal artery stenosis is strongly sus-
pected. These patients then undergo a selective angiography for
identification of pudendal artery stenosis. If the stenosis is found,
they are subjected to super selective pudendal artery cannulation
and angioplasty or stenting using drug eluting balloon (DEB) or
zotarolimus eluting stents (DES). Patients are followed up at 3, 9,
12 months and then after every year by Duplex scans.
Results: 36 consecutive worked up patients of complex ED with
pudendal artery stenosis underwent pudendal artery angioplasty
(with DEB or DES). The procedure was successful in all patients.
There was no death, perineal or penile gangrene. Themean penile
velocity increased from base line of 16cm/sec to 44, 50, 58cm/sec
at 3, 6, 12 months respectively. Improvement > 4 points in Inter-
national Index of Erectile Functions (IIEF -6) score at 3, 6 and 12
months were 68 %, 75 % and 78 % respectively.
Conclusions: Angioplasty of focal stenosis of internal pudendal
artery by DEB or DES appears to be a very promising therapy for
male erectile dysfunction. It is safe, feasible and leads to sustained
improvement of male erectile dysfunction.
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Background: Central venous occlusions (CVOs) are a common
complication that may arise after the placement of central venous
catheters, especially in patients of chronic renal failure undergo-
ing maintenance hemodialysis and patients with indwelling
pacemaker leads. Patients may present with Superior Vena Cava
(SVC) syndrome (symptoms of upper limb and cranial venous
hypertension leading to swelling of face and upper limbs) and
inability to continuewith hemodialysis. Till recently, there was no
satisfactory and durable treatment for these patients, but of late,
endovascular recanalization of CVOs has become feasible and a
successful treatment option in these patients. Surgery carries a
very high morbidity as is often unsuccessful.
Methods: Patients presented with SVC syndrome. Diagnosis of
CVO was made by angiography. Anatomical details like site and
length of occlusion, collateral pathways, presence or absence of
thrombus and distal venous anatomy were noted. The CVOs were
recanalised through either femoral, brachial or subclavian
approach using 0.035” hydrophilic guide wires, extra backup
telescopic catheters, non compliant peripheral balloons (Mustang,
Boston Scientific) and self expanding stent implantation (Epic,
Boston Scientific). Patients were kept on dual antiplatelet for one
month followed by Aspirin 150mg daily. Hemodialysis was initi-
ated immediately after the procedure.
Results: N ¼ 97; Subclavian Vein - 35; Brachiocepahlic Vein 13;
Superior Vena Cava 23 and Combined Lesions - 26 Technical
Success in 91 /97; Percutaneous Transluminal Angioplasty (PTA)
in 69; Stents-22 and Catheter Directed Thrombolytic Therapy
(CDTT) 23 Patency: Primary (at 6 months) : 48%, Secondary (at 1
year) : 87%.
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